Let's Talk Legal Workshop | Venture Financing: What to Expect and Strategies for Success

Add this event to your calendar:
02/11/2017 11:30 02/11/2017 14:00 America/Los_Angeles Let's Talk Legal Workshop | Venture Financing: What to Expect and Strategies for Success JLABS @ SSF , 329 Oyster Point Blvd , South San Francisco , CA 94080 JLABS Bay Area false DD/MM/YYYY
November
2
Event

Let's Talk Legal Workshop | Venture Financing: What to Expect and Strategies for Success

JLABS @ SSF , 329 Oyster Point Blvd , South San Francisco , CA 94080

November 02, 2017 from 11:30 AM to 14:00 PM (PST)

$10 - $35



Join us for "Let's Talk Legal I Venture Financing: What to Expect and Strategies for Success" –a workshop designed to help entrepreneurs demystify the legal landscape and fill in the blanks. The program is interactive and informal so bring your questions with you!


Program Overview

You're past the initial stages in establishing your startup company and are ready to take it to the next level - raising capital. What should you expect during a pivotal early stage company financing round and what are the strategies for ensuring you meet your objectives and protect your interests?

This practical session will focus on how to approach a venture financing round - key topics include:

  • Venture capital financing deal structures
  • Key deal terms that are commonly subject to heavy negotiation
  • Considerations for protecting founder interests
  • Strategic investors v. venture capital investors


Agenda:
10:30 AM - 11:00 AM | Registration & Networking
11:00 AM - 11:45 AM | Presentation
11:45 AM - 12:00 PM | Q&A
12:00 PM - 1:00 PM | Lunch and Networking
1:00 PM | Program Close

This event is brought to you by Johnson & Johnson's law department working in close partnership with Ropes & Gray LLP, a preeminent global law firm with deep expertise in life sciences. The lawyers presenting these workshops have extensive experience working with life sciences companies ranging from very early-stage startup companies to global public companies..

Speakers
Stuart Wilks | Assistant General Councel, Johnson & Johnson read bio»
Steven A. Wilcox | Partner, Ropes & Gray read bio»
Brad Flint | Associate, Ropes & Gray read bio»


Fees:
$25 | General Public
$10 | Student/Academic
$35 | At the door
** Please note: fees do not go to the presenting lawyers, they cover only a portion of catering and event costs


Location:
JLABS @ SSF
329 Oyster Point Blvd. Floor 3
South San Francisco, CA 94080


Speakers' Biographies:

Stuart Wilks | Assistant General Counsel, Johnson & Johnson
Stuart is Assistant General Counsel at Johnson & Johnson resident at the Johnson & Johnson Innovation Center in Menlo, Park California. In this role, Stuart provides general legal advice to the Innovation Center team in California, participates directly as legal counsel in Innovation Center transactions, and/or coordinates with colleagues in the Johnson & Johnson Law Department to support Innovation Center matters.

During his nearly fifteen years with Johnson & Johnson, in addition to the California Innovation Center, Stuart has supported a diverse group of Johnson & Johnson operating companies and units, such as Alza, BabyCenter, Janssen Health Innovation, Janssen Research & Development, Janssen Supply Chain, Johnson & Johnson Innovation – JJDC, Inc., Noramco, and Scios in a broad range of business and contractual matters. Prior to joining Johnson & Johnson, Stuart was corporate counsel at Scios, Inc. in Fremont, California, corporate counsel at COR Therapeutics, Inc. in South San Francisco, California and an associate in the corporate and life sciences practice groups of the Palo Alto office of Cooley LLP.
Connect with Stuart:   Connect on LinkedIn



Steven A. Wilcox | Partner, Ropes & Gray
Steve Wilcox focuses his practice on mergers and acquisitions, corporate financing transactions (including public offerings and venture capital investments) and licensing and collaborations. Most of his clients are engaged in the biotech, medical device and pharmaceutical industries. In addition to transactional work, he regularly counsels companies on a range of federal securities and corporate governance matters.

Steve is a founder and former chair of the firm's life sciences practice group.

Steve has been counsel to some of the world's leading companies including Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Fresenius, Johnson & Johnson, Medtronic, Millennium, Pfizer, Schering Plough, Smith & Nephew and Takeda Pharmaceuticals. Steve has also represented medical research institutions such as Cleveland Clinic, The Massachusetts General Hospital and Rockefeller University in connection with the spin-off or commercialization of their promising technologies. Steve has represented a number of entrepreneurs and venture capitalists in the life sciences industry, and the companies they have created, including AgeneBio, Alzheon, Blossom Innovations, Eléme Medical, InfoBionic, Normoxys, Percardia, pHLIP, Inc., Point Therapeutics, Salient Surgical, Vapotherm and Verax Biomedical.
Connect with Steven:   Connect on LinkedIn



Bradford Flint | Associate, Ropes & Gray
Brad advises a broad range of public and private company clients on start-up and formation matters, corporate governance, debt and equity financing, mergers and acquisitions, technology licensing and transfer, collaboration arrangements, supply and distribution agreements, and other general corporate matters. Brad represents clients in a variety of industries including biotechnology, pharmaceutical, medical device, software, and technology. He also regularly represents venture capital and private equity investors in connection with portfolio company investments and acquisitions.<
Connect with Bradford:   Connect on LinkedIn


JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact


Related content